Opthea in crisis as eye treatment fails in spectacular default
MELBOURNE: Biotechnology firm Opthea has warned investors its solvency is in question after the failure… read more
Regal Funds loses $100m following Opthea’s medical trial failure
MELBOURNE: Investors have wiped more than $100m from the value of Regal Funds, amid fears… read more
Healthscope flatlining and clock is ticking on its demise
MELBOURNE: Investors are feeling the pain after one of Healthscope’s biggest landlords, a property trust… read more
WCH surgery patients “put at risk” due to unsafe equipment
ADELAIDE: Dozens of children and female patients were put at risk during surgery after medically… read more
